Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.

A highly invasive human glioblastoma pre-clinical model for testing therapeutics.

Xie Q, Thompson R, Hardy K, DeCamp L, Berghuis B, Sigler R, Knudsen B, Cottingham S, Zhao P, Dykema K, Cao B, Resau J, Hay R, Vande Woude GF.

J Transl Med. 2008 Dec 3;6:77. doi: 10.1186/1479-5876-6-77.

2.

The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo.

Tsai NM, Lin SZ, Lee CC, Chen SP, Su HC, Chang WL, Harn HJ.

Clin Cancer Res. 2005 May 1;11(9):3475-84.

3.

Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.

Schwock J, Dhani N, Cao MP, Zheng J, Clarkson R, Radulovich N, Navab R, Horn LC, Hedley DW.

Cancer Res. 2009 Jun 1;69(11):4750-9. doi: 10.1158/0008-5472.CAN-09-0454.

4.

Mouse models in oncogenesis and cancer therapy.

Céspedes MV, Casanova I, Parreño M, Mangues R.

Clin Transl Oncol. 2006 May;8(5):318-29. Review.

PMID:
16760006
5.

Establishment of a new human glioblastoma multiforme cell line (WJ1) and its partial characterization.

Wang J, Wang X, Jiang S, Lin P, Zhang J, Wu Y, Xiong Z, Ren JJ, Yang H.

Cell Mol Neurobiol. 2007 Nov;27(7):831-43.

PMID:
17703357
6.

Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme.

Bryant NL, Gillespie GY, Lopez RD, Markert JM, Cloud GA, Langford CP, Arnouk H, Su Y, Haines HL, Suarez-Cuervo C, Lamb LS Jr.

J Neurooncol. 2011 Jan;101(2):179-88. doi: 10.1007/s11060-010-0245-2.

PMID:
20532954
7.

Why are systemic glioblastoma metastases rare? Systemic and cerebral growth of mouse glioblastoma.

Mourad PD, Farrell L, Stamps LD, Chicoine MR, Silbergeld DL.

Surg Neurol. 2005 Jun;63(6):511-9; discussion 519.

PMID:
15936366
8.
9.

Orthotopically implanted SCID mouse model of human lung cancer suitable for investigating metastatic potential and anticancer drug effects.

Kondo K, Fujino H, Miyoshi T, Ishikura H, Sakiyama S, Monden Y.

Oncol Rep. 2004 Nov;12(5):991-9.

PMID:
15492783
10.

STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma.

Geng L, Shinohara ET, Kim D, Tan J, Osusky K, Shyr Y, Hallahan DE.

Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):263-71.

PMID:
16274936
11.

Antitumor activity of F90, an epidermal growth factor receptor tyrosine kinase inhibitor, on glioblastoma cell line SHG-44.

Liu FJ, Gui SB, Li CZ, Sun ZL, Zhang YZ.

Chin Med J (Engl). 2008 Sep 5;121(17):1702-6.

PMID:
19024103
12.

Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models.

Pisati F, Belicchi M, Acerbi F, Marchesi C, Giussani C, Gavina M, Javerzat S, Hagedorn M, Carrabba G, Lucini V, Gaini SM, Bresolin N, Bello L, Bikfalvi A, Torrente Y.

Cancer Res. 2007 Apr 1;67(7):3054-63.

13.

Identification of genes involved in the sensitivity to antitumour drug 17-allylamino,17-demethoxygeldanamycin (17AAG).

Barresi V, Fortuna CG, Garozzo R, Musumarra G, Scirè S, Condorelli DF.

Mol Biosyst. 2006 May;2(5):231-9.

PMID:
16880941
14.

CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy.

Bao R, Lai CJ, Qu H, Wang D, Yin L, Zifcak B, Atoyan R, Wang J, Samson M, Forrester J, DellaRocca S, Xu GX, Tao X, Zhai HX, Cai X, Qian C.

Clin Cancer Res. 2009 Jun 15;15(12):4046-57. doi: 10.1158/1078-0432.CCR-09-0152.

15.

CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas.

Redjal N, Chan JA, Segal RA, Kung AL.

Clin Cancer Res. 2006 Nov 15;12(22):6765-71.

16.

Herbal extract "Songyou Yin" inhibits tumor growth and prolongs survival in nude mice bearing human hepatocellular carcinoma xenograft with high metastatic potential.

Huang XY, Wang L, Huang ZL, Zheng Q, Li QS, Tang ZY.

J Cancer Res Clin Oncol. 2009 Sep;135(9):1245-55. doi: 10.1007/s00432-009-0566-8.

PMID:
19277711
18.

Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms.

Miletic H, Niclou SP, Johansson M, Bjerkvig R.

Expert Opin Ther Targets. 2009 Apr;13(4):455-68. doi: 10.1517/14728220902806444 . Review.

PMID:
19335067
19.

Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme.

Gossmann A, Helbich TH, Kuriyama N, Ostrowitzki S, Roberts TP, Shames DM, van Bruggen N, Wendland MF, Israel MA, Brasch RC.

J Magn Reson Imaging. 2002 Mar;15(3):233-40.

PMID:
11891967
20.

A bioluminescent orthotopic mouse model of human osteosarcoma that allows sensitive and rapid evaluation of new therapeutic agents In vivo.

Comstock KE, Hall CL, Daignault S, Mandlebaum SA, Yu C, Keller ET.

In Vivo. 2009 Sep-Oct;23(5):661-8.

Items per page

Supplemental Content

Support Center